TABLE 2.
Clinicopathologic Characteristics, Serum Anti-HCV, and HCV NS3 Immunostaining in Serum HCV-RN Positive B-cell Non-Hodgkin Lymphoma Patients (n = 39)
| Patient Number |
Age (y) | Sex | EN | Diagnosis | Serum Anti-HCV |
HCV-NS3 Protein |
|---|---|---|---|---|---|---|
| 1 | 68 | M | No | SLL | + | − |
| 2 | 39 | M | No | DLBCL | + | − |
| 3 | 50 | M | No | FL | + | − |
| 4 | 57 | F | No | DLBCL | + | − |
| 5 | 71 | M | Yes | DLBCL | + | − |
| 6 | 51 | M | Yes | DLBCL | + | − |
| 7 | 41 | M | No | DLBCL | + | − |
| 8 | 56 | F | No | TCRLBL | + | − |
| 9 | 51 | F | Yes | DLBCL | + | − |
| 10 | 69 | M | No | DLBCL | − | − |
| 11 | 30 | M | No | DLBCL | + | − |
| 12 | 58 | F | No | DLBCL | + | − |
| 13 | 68 | M | No | DLBCL | + | − |
| 14 | 27 | M | No | DLBCL | + | − |
| 15 | 60 | F | No | DLBCL | + | + |
| 16 | 52 | F | No | TCRLBL | + | − |
| 17 | 34 | F | Yes | DLBCL | + | + |
| 18 | 48 | M | No | DLBCL | + | − |
| 19 | 52 | F | No | DLBCL | + | − |
| 20 | 72 | M | No | DLBCL | + | − |
| 21 | 38 | M | Yes | FL | + | − |
| 22 | 40 | M | No | DLBCL | + | − |
| 23 | 56 | F | No | DLBCL | + | − |
| 24 | 62 | M | No | SLL | + | + |
| 25 | 51 | M | Yes | DLBCL | + | + |
| 26 | 53 | F | No | MZL | + | − |
| 27 | 68 | M | No | FL | + | − |
| 28 | 53 | M | No | DLBCL | + | + |
| 29 | 68 | F | No | DLBCL | + | + |
| 30 | 53 | F | No | FL | + | − |
| 31 | 51 | F | No | DLBCL | + | − |
| 32 | 63 | M | No | DLBCL | + | − |
| 33 | 59 | F | Yes | DLBCL | + | − |
| 34 | 74 | M | No | FL | + | − |
| 35 | 48 | F | No | FL | + | + |
| 36 | 55 | M | No | FL | + | − |
| 37 | 61 | F | No | SLL | + | − |
| 38 | 55 | F | No | DLBCL | + | + |
| 39 | 41 | M | No | DLBCL | + | − |
DLBCL indicates diffuse large B-cell lymphoma; EN, extranodal presentation; F, female; FL, follicular lymphoma; HCV, hepatitis C virus; M, male; MZL, marginal zone lymphoma; SLL, small lymphocytic lymphoma; TCRLBL, T-cell rich large B-cell lymphoma.